The CIS family: Negative regulators of JAK-STAT signaling

Cytokine and Growth Factor Reviews

Volumn 9, Issue 3-4, 1998, Pages 197-204

  Yoshimura, Akihiko ^a  

^a KURUME UNIVERSITY   (Japan)

Author keywords

Cytokine; JAK; Regulation; SH2 domain; STAT

Indexed keywords

CIS PROTEIN; CYTOKINE; DNA BINDING PROTEIN; IMMEDIATE EARLY PROTEIN; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; MAMMARY GLAND-SPECIFIC NUCLEAR FACTOR; PROTEIN; PROTEIN TYROSINE KINASE; SOCS-3 PROTEIN; TRANSACTIVATOR PROTEIN; TYK2 PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL; CARBOXY TERMINAL SEQUENCE; CYTOKINE PRODUCTION; HUMAN; MOLECULAR GENETICS; NEGATIVE FEEDBACK; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; HUMANS; IMMEDIATE-EARLY PROTEINS; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; MILK PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TYK2 KINASE;

EID: 0344820725     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00019-7     Document Type: Short Survey

References (46)

1. O'Shea JJ, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 1997, 7, 1-11.
2. Ihle, JN. Cytokine receptor signaling. Nature 1995, 377, 591-594.
3. Darnell JE Jr. STATs and Gene Regulation. Science 1997, 277, 1630-1635.
4. Ihle JN. STATs: Signal transducers and activators of transcription. Cell 1996, 84, 331-334.
5. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84, 443-450.
6. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84, 431-442.
7. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996, 382, 174-177.
8. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN. Lack of 11-4 induced TH2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996, 380, 630-633.
9. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S. Essential role of Stat6 in IL-4 signaling. Nature 1996, 380, 627-630.
10. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U.S.A. 1997, 94, 7239-7244.
11. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 1997, 11, 179-186.
12. Nakajima H, Liu XW, Wynshaw-Boris A, Rosenthal LA, Imada K, Finbloom DS, Hennighausen L, Leonard WJ. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 1997, 7, 691-701.
13. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93, 841-850.
14. Rook GA, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994, 15, 301-303.
15. Sengupta TK, Schmitt EM, Ivashkiv LB. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sci U.S.A. 1996, 93, 9499-9504.
16. Kim TK, Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 1996, 273, 1717-1719.
17. Strous GJ, van Kerkhof P, Govers R, Ciechanover A, Schwartz AL. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J 1996, 15, 3806-3812.
18. Wang D, Stravopodis D, Teglund S, Kitazawa J, Ihle JN. Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 1996, 16, 6141-6148.
19. Azam M, Lee C, Strehlow I, Schindler C. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 1997, 6, 691-701.
20. Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 1997, 90, 2057-2061.
21. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995, 80, 729-738.
22. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Kara T, Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-physphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995, 14, 2816-2826.
23. Uchida K, Yoshimura A, Inazawa J, Yanagisawa K, Osada H, Masuda A, Saito T, Takahashi T, Miyajima A, Takahashi T. Molecular cloning of CISH, chromosome assignment to 3p21.3, and analysis of expression in fetal and adult tissues. Cytogenet Cell Genet 1997, 78, 209-212.
24. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997, 89, 3148-3154.
25. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387, 917-921.
26. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997, 387, 921-924.
27. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997, 387, 924-929.
28. Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mutsui K, Wakioka T, Tanimura S, Sasaki A, Misawa H, Yokouchi M, Ohtsubo M, Yoshimura A. Cloning and Characterization of Novel CIS Family Genes. Biochem Biophys Res Commun 1997, 239, 439-446.
29. Ohya Ki, Kajigaya S, Yamashita Y, Myazato A, Hatake K, Miura Y, Ikeda U, Shimada K, Ozawa K, Mano H. SOCS-1/JAB/SS1-1 can bind to and suppress Tec protein-tyrosine kinase. J Biol Chem 1997, 272, 27,178-27,182.
30. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U.S.A. 1998, 95, 114-119.
31. Matuoka K, Miki H, Takahashi K, Takenawa T. A novel ligand for an SH3 domain of the adaptor protein Nek bears an SH2 domain and nuclear signaling motifs. Biochem Biophys Res Commun 1997, 239, 488-492.
32. Bjorbaek C, Elquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998, 4, 619-625.
33. Auernhammer CJ, Chesnokova V, Bousquet C, Melmed S. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol 1998, 12, 954-961.
34. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998, 93, 827-839.
35. Suzuki R, Sakamoto H, Yawukawa H, Masuhara M, Wakioka T, Sasaki A, Yuge K, Yokouchi M, Komiya S, Inoue A, Yoshimura A. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene, in press.
36. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S, Kishimoto T. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-1 and SSI-3. Biochem Biophys Res Commun 1997, 237, 79-83.
37. Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka S, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A. A Janus kinase inhibitor, JAB, is an interferon-γ inducible gene and confers resistance to interferon. Blood 1998, 92, 1668-1676.
38. Schluter G, Celik A, Obata R, Schlicker M, Hofferbert S, Schlung A, Adham IM, Engel W. Sequence analysis of the conserved protamine gene cluster shows that it contains a fourth expressed gene. Mol Reprod Devel 1996, 43, 1-6.
39. Xu L, Rothman P. IFN-γ represses ε germline transcription and subsequently down-regulates switch recombination to epsilon. Int Immunol 1994, 6, 515-521.
40. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med 1994, 179, 1367-1371.
41. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 1995, 269, 245-247.
42. Fukunaga R, Ishizaka-Ikeda E, Pan CX, Seto Y, Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 1991, 10, 2855-2865.
43. Yamamura Y, Kageyama Y, Matuzaki T, Noda M, Ikawa Y. Dinstict downstream signaling mechanism between erythropoietin receptor and interleukin-2 receptor. EMBO J 1992, 11, 4909-4915.
44. Wakao H, Harada N, Kitamura T, Mui AL-F, Miyajima A. Interleukin 2 (IL2) and erythropoietin (EPO) activate STAT5/MGF via distinct pathways. EMBO J 1995, 14, 2527-2535.
45. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264, 1415-1421.
46. Verdier F, Chretien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C, Mayeux P. Proteasomes regulate erythropoietin receptor and STAT5 activation: possible involvement of the ubiquitinated CIS protein. J Biol Chem, in press.